Skip to main content
Log in

Low doses of rHuEPO administered to adult patients with thalassemia intermedia

  • Letter to the Editer
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Olivieri NF, Freedman MH, Perrine SP, Dover GJ, Sheridan B (1992) Trial of recombinant human erythropoietin: three patients with thalassemia intermedia. Blood 80:3258 (Letter)

    PubMed  Google Scholar 

  2. Rachmilewitz EA, Goldfarb A, Dover G (1991) Administration of erythropoietin to patients withβ-thalassemia intermedia: a preliminary trial. Blood 78:1145 (Letter)

    PubMed  Google Scholar 

  3. Andre M, Bergman P, Ferster A, Toppet M, Fondu P (1991) Serum immunoreactive erythropoietin level: a new parameter for monitoring transfusion management of thalassaemia. Nouv Rev Fr Hematol 33:299

    PubMed  Google Scholar 

  4. Dore F, Bonfigli S, Gaviano E, Pardini S, Cianciulli P, Papa G, Longinotti M (1993) Serum erythropoietin levels in thalassemia intermedia. Ann Hematol 67:183

    PubMed  Google Scholar 

  5. Koury MJ, Bondurant ML (1992) The molecular mechanism of erythropoietin action. Eur J Biochem 210:49

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dore, F., Gaviano, E., Bonfigli, S. et al. Low doses of rHuEPO administered to adult patients with thalassemia intermedia. Ann Hematol 69, 211–212 (1994). https://doi.org/10.1007/BF02215956

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02215956

Keywords

Navigation